Intratio
Quantitative Research
Skip to main content
AI Market Summary
Loading market intelligence...
  • Sign in
    My account
    Logout
AI 90-DAY FORECAST
NEUTRAL SIGNAL
██.█% Sign up free to reveal

Nrx Pharmaceuticals, Inc. (NRXP) AI Forecast

Our AI analyzed Nrx Pharmaceuticals, Inc.. Create a free account to see the 90-day price prediction.

✓ Free account • ✓ 30-day free trial

$NRXP Neutral Signal Full forecast available
Sign Up Free

Nrx Pharmaceuticals, Inc. (NRXP) Stock Forecast 2025

Nrx Pharmaceuticals, Inc. (NRXP) AI Stock Price Forecast & Investment Analysis

Nrx Pharmaceuticals, Inc. Stock Price Chart and Technical Analysis

Loading chart...

Nrx Pharmaceuticals, Inc. (NRXP) - Comprehensive Stock Analysis & Investment Research

Deep dive into Nrx Pharmaceuticals, Inc.'s business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Analysis updated on July 22, 2026, 4:24 p.m. (UTC)

Nrx Pharmaceuticals, Inc. Investment Summary

When evaluating whether Nrx Pharmaceuticals, Inc. (NRXP) represents a compelling investment opportunity, investors must consider multiple factors including the company's financial health, market position, growth prospects, and what our AI-powered predictive models suggest about its near-term price trajectory.

Company Profile

Nrx Pharmaceuticals, Inc. (NRXP) operates within the Life Sciences sector, specifically in the Pharmaceutical Preparations industry. . With a market capitalization of $191 million, the company is a small-cap stock that may offer higher growth potential but also carries higher volatility.

Financial Performance Analysis

Our comprehensive financial analysis covers Nrx Pharmaceuticals, Inc.'s revenue, profitability metrics, balance sheet strength, and cash flow generation...

AI Price Predictions

Get AI-powered 7-day, 30-day and 90-day price forecasts for Nrx Pharmaceuticals, Inc. along with confidence scores and detailed analysis...

Investment Considerations

Expert analysis of whether Nrx Pharmaceuticals, Inc. is suitable for your investment objectives, risk tolerance, and time horizon...

Continue Reading Full Analysis

Get the complete investment breakdown for Nrx Pharmaceuticals, Inc.

Sign Up Free
Corporate Identity

Nrx Pharmaceuticals, Inc. (Stock Symbol: NRXP) is a prominent company operating within the Life Sciences sector, with a specific focus on the Pharmaceutical Preparations industry. The company's shares are publicly traded on the Nasdaq exchange.

Leadership & Workforce

Detailed information about Nrx Pharmaceuticals, Inc.'s leadership team, workforce size, and organizational structure...

Market Classification

Market capitalization analysis and stock classification (mega-cap, large-cap, mid-cap, small-cap) for Nrx Pharmaceuticals, Inc....

Sector & Industry Analysis

In-depth sector dynamics and industry context for Nrx Pharmaceuticals, Inc....

Unlock Full Company Profile

Get complete details about Nrx Pharmaceuticals, Inc.

Sign Up Free
Revenue & Growth Analysis

Nrx Pharmaceuticals, Inc. generates annual revenues of $2 million , representing an emerging company in its growth phase.

Profitability Metrics

Net profit margin, gross margin, and operating margin analysis for Nrx Pharmaceuticals, Inc....

Market Valuation

P/E ratio, price-to-book, and valuation multiples for Nrx Pharmaceuticals, Inc....

Return Metrics

Return on equity (ROE), return on assets (ROA), and capital efficiency for Nrx Pharmaceuticals, Inc....

Unlock Financial Analysis

Get complete financial metrics for Nrx Pharmaceuticals, Inc.

Sign Up Free
AI ANALYSIS AVAILABLE

Unlock Nrx Pharmaceuticals, Inc.'s AI Price Forecast

Join 10,000+ investors using our 67%+ accurate AI predictions

4,000+ Stocks Analyzed
67%+ Accuracy Rate
Daily Updates
Start 30-Day Free Trial →

✓ 30-day free trial • ✓ Cancel anytime

Strategic Market Position

Nrx Pharmaceuticals, Inc. strategically competes in the highly dynamic Pharmaceutical Preparations marketplace. As a small-cap company, it represents an emerging market participant with potentially significant growth opportunities. Small-caps often offer greater growth potential as they capture market share and scale their operations, though this comes with higher risk and volatility. Success at this stage can lead to substantial returns for early investors who identify winning business models.

Industry Competitive Landscape

Nrx Pharmaceuticals, Inc. competes within the Life Sciences sector, navigating the competitive dynamics and market forces specific to this industry. The company's competitive position depends on its ability to differentiate through product quality, cost efficiency, customer relationships, or other strategic advantages relevant to its specific market segment.

Operational Efficiency
Asset Utilization Efficiency

Asset turnover ratio of 0.24x indicates lower asset turnover that may reflect the industry's capital-intensive nature or potentially underutilized assets. Companies with low turnover typically depend on strong margins to generate adequate returns on capital.

Financial Strength & Leverage

Current ratio of 0.29 reflects potential liquidity concerns with current liabilities exceeding current assets. While some businesses operate successfully with negative working capital, this warrants understanding of the specific circumstances.

Nrx Pharmaceuticals, Inc. (NRXP) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for Nrx Pharmaceuticals, Inc. stock analysis.

Deep dive into Nrx Pharmaceuticals, Inc.'s financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if Nrx Pharmaceuticals, Inc. stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For Nrx Pharmaceuticals, Inc.:

Market Cap $191M
Revenue/Share $0.07
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently Nrx Pharmaceuticals, Inc. converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Nrx Pharmaceuticals, Inc.: An ROE of 0.8% indicates room for improvement in shareholder value creation.

ROE 0.8%
ROA -0.9%
ROIC 1.0%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess Nrx Pharmaceuticals, Inc.'s ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For Nrx Pharmaceuticals, Inc.: A current ratio of 0.29 suggests potential liquidity concerns.

Current Ratio 0.29x
D/E Ratio -1.86x
Financial Leverage -0.86x
Interest Coverage -28.4x
Working Capital -$18M
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal Nrx Pharmaceuticals, Inc.'s ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For Nrx Pharmaceuticals, Inc.:

Operating Cash Flow -$140K
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively Nrx Pharmaceuticals, Inc. uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For Nrx Pharmaceuticals, Inc.: An asset turnover of 0.24x suggests room for improvement in asset utilization.

Asset Turnover 0.24x
Receivables Turnover 15.8x
Fixed Assets Turnover 11.0x
Days Sales Outstanding 23 days
Understanding Financial Statement Data

What these metrics mean: Key figures from Nrx Pharmaceuticals, Inc.'s income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For Nrx Pharmaceuticals, Inc.: With annual revenue of $2M, Nrx Pharmaceuticals, Inc. represents a smaller but potentially high-growth operation.

Income Statement
Total Revenue $2M
Balance Sheet Highlights (% Of Assets)
Total Current Assets 7%
Cash & Short-term Investments 7%
Total Liabilities 26%
Short-term Debt 21%
Accounts Receivable 0%
Dividend & Shareholder Information
Shares Outstanding 43M

Latest Nrx Pharmaceuticals, Inc. Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting Nrx Pharmaceuticals, Inc. (NRXP) stock price and investment outlook.

More news available

Sign up free to read all 10 news articles and stay updated on market developments.

Sign Up Free to Read More

Nrx Pharmaceuticals, Inc. Competitors & Peer Analysis - Life Sciences Sector

Comparative analysis of Nrx Pharmaceuticals, Inc. against industry peers and competitors in the Life Sciences sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
Aardvark Therapeutics, Inc. AARD ██% $133M x 1.5x
Abbvie Inc. ABBV ██% $453.21B 124.7x x
Abcellera Biologics Inc. ABCL ██% $1.81B x 1.9x
Abeona Therapeutics Inc. ABEO ██% $372M 5.6x 2.6x
Abbott Laboratories ABT ██% $173.62B 27.7x 3.3x
Arbutus Biopharma Corp ABUS ██% $890M 5.5x 3.4x
Abvc Biopharma, Inc. ABVC ██% $31M x 2.9x
Abivax S.A. ABVX ██% $10.29B x x
Acadia Pharmaceuticals Inc ACAD ██% $4.35B 11.6x 3.5x
Adicet Bio, Inc. ACET ██% $76M x 0.5x
Aclaris Therapeutics, Inc. ACRS ██% $795M x 5.5x
Acrivon Therapeutics, Inc. ACRV ██% $68M x 0.7x
Accustem Sciences Inc. ACUT ██% $4M x x
Acurx Pharmaceuticals, Inc. ACXP ██% $7M x 0.9x
Adagene Inc. ADAG ██% $238M x 6.3x
Adc Therapeutics Sa ADCT ██% $162M x x
Adial Pharmaceuticals, Inc. ADIL ██% $6M x 1.6x
Aditxt, Inc. ADTX ██% $3M x x
Addex Therapeutics Ltd. ADXN ██% $7M x x
Aeon Biopharma, Inc. AEON ██% $13M x x
Agios Pharmaceuticals, Inc. AGIO ██% $2.22B x 2.0x
Akebia Therapeutics, Inc. AKBA ██% $348M x 12.7x
Akari Therapeutics Plc AKTX ██% $16M x 1.1x
Aldeyra Therapeutics, Inc. ALDX ██% $106M x 2.5x
Alkermes Plc. ALKS ██% $8.80B 57.6x 5.0x
Allarity Therapeutics, Inc. ALLR ██% $19M x 2.8x
Alumis Inc. ALMS ██% $3.76B x 6.6x
Alnylam Pharmaceuticals, Inc. ALNY ██% $35.92B 114.5x 45.5x
Altimmune, Inc. ALT ██% $548M x 1.9x
Alx Oncology Holdings Inc ALXO ██% $276M x 1.8x
Alzamend Neuro, Inc. ALZN ██% $5M x 2.3x
Amylyx Pharmaceuticals, Inc. AMLX ██% $2.05B x 7.5x
Amphastar Pharmaceuticals, Inc. AMPH ██% $874M 11.0x 1.1x
Amarin Corp Plc\Uk AMRN ██% $292M x 0.7x
Amneal Pharmaceuticals, Inc. AMRX ██% $5.72B 46.8x x
Anaptysbio, Inc ANAB ██% $1.56B x 122.4x
Anebulo Pharmaceuticals, Inc. ANEB ██% $14M x 1.7x
Ani Pharmaceuticals Inc ANIP ██% $1.66B 18.0x 2.9x
Anixa Biosciences Inc ANIX ██% $121M x 8.3x
Annexon, Inc. ANNX ██% $821M x 4.0x
Alto Neuroscience, Inc. ANRO ██% $949M x 3.9x
An2 Therapeutics, Inc. ANTX ██% $180M x 2.2x
Annovis Bio, Inc. ANVS ██% $74M x 23.8x
Apollomics Inc. APLM ██% $41M x x
Aprea Therapeutics, Inc. APRE ██% $8M x 0.2x
Apimeds Pharmaceuticals Us, Inc. APUS ██% $10M x 0.1x
Aptevo Therapeutics Inc. APVO ██% $5M x 0.5x
Aquestive Therapeutics, Inc. AQST ██% $502M x x
Arcturus Therapeutics Holdings Inc. ARCT ██% $170M x 0.9x
Ardelyx, Inc. ARDX ██% $1.26B x 8.5x
Arcutis Biotherapeutics, Inc. ARQT ██% $3.53B x 18.6x
Artelo Biosciences, Inc. ARTL ██% $4M x 0.6x
Arvinas, Inc. ARVN ██% $533M x 1.4x
Arrowhead Pharmaceuticals, Inc. ARWR ██% $10.48B x 17.1x
Aspire Biopharma Holdings, Inc. ASBP ██% $10M x 2.5x
Assembly Biosciences, Inc. ASMB ██% $525M x 2.6x
Ascendis Pharma A/S ASND ██% $15.82B x x
Assertio Holdings, Inc. ASRT ██% $151M x 2.0x
Atai Beckley N.V. ATAI ██% $2.64B x 16.5x
Alterity Therapeutics Ltd ATHE ██% $90M x x
Actinium Pharmaceuticals, Inc. ATNM ██% $28M x 12.3x
Atossa Therapeutics, Inc. ATOS ██% $24M x 0.8x
Avenue Therapeutics, Inc. ATXI ██% $820K x 0.7x
Aurinia Pharmaceuticals Inc. AUPH ██% $2.05B 6.9x 3.6x
Arrivent Biopharma, Inc. AVBP ██% $1.28B x 4.0x
Atea Pharmaceuticals, Inc. AVIR ██% $390M x 1.7x
Avalo Therapeutics, Inc. AVTX ██% $989M x 14.5x
Axim Biotechnologies, Inc. AXIM ██% $1M x x
Axsome Therapeutics, Inc. AXSM ██% $12.18B x 223.2x
Azitra, Inc. AZTR ██% $2M x 0.2x
Bridgebio Pharma, Inc. BBIO ██% $16.14B x x
Bridgebio Oncology Therapeutics, Inc. BBOT ██% $698M x 1.9x
Bicara Therapeutics Inc. BCAX ██% $1.85B x 3.6x
Briacell Therapeutics Corp. BCTX ██% $33M x 1.4x
Bicycle Therapeutics Plc BCYC ██% $290M x 0.5x
Bioadaptives, Inc. BDPT ██% $20K x x
Biodexa Pharmaceuticals Plc BDRX ██% $2M x x
Bullfrog Ai Holdings, Inc. BFRG ██% $12M x 2.4x
Biofrontera Inc. BFRI ██% $13M x 2.1x
Bausch Health Companies Inc. BHC ██% $1.69B x x
Bioharvest Sciences Inc. BHST ██% $52M x 2.0x
Bioage Labs, Inc. BIOA ██% $1.01B x 2.7x
Bio Essence Corp BIOE ██% $13M 9.7x x
Biovie Inc. BIVI ██% $10M x 0.6x
Bioxytran, Inc BIXT ██% $3M x x
Biolinerx Ltd. BLRX ██% $13M x x
Belite Bio, Inc BLTE ██% $6.34B x 8.2x
Biomea Fusion, Inc. BMEA ██% $96M x 5.1x
Biomarin Pharmaceutical Inc BMRN ██% $11.44B 42.6x 1.8x
Bristol Myers Squibb Co BMY ██% $124.18B 17.1x 6.2x
Benitec Biopharma Inc. BNTC ██% $408M x 2.2x
Boundless Bio, Inc. BOLD ██% $56M x 0.6x
Bolt Biotherapeutics, Inc. BOLT ██% $8M x 0.4x
Bio-Path Holdings, Inc. BPTH ██% $2M x x
Bioquest Corp BQST ██% $2M x x
Barinthus Biotherapeutics Plc. BRNS ██% $25M x 0.4x
Bespoke Extracts, Inc. BSPK ██% $1M x x
Bioxcel Therapeutics, Inc. BTAI ██% $28M x x
Beyondspring Inc. BYSI ██% $51M x x
Calcimedica, Inc. CALC ██% $11M x x
Can-Fite Biopharma Ltd. CANF ██% $7M x 1.3x
Capricor Therapeutics, Inc. CAPR ██% $1.14B x 4.1x
Perspective Therapeutics, Inc. CATX ██% $340M x 1.0x
Gyre Therapeutics, Inc. CBIO ██% $594M x 5.9x
Cdt Equity Inc. CDT ██% $2M x x
Cingulate Inc. CING ██% $64M x 3.4x
Cell Source, Inc. CLCS ██% $65M x x
Clene Inc. CLNN ██% $69M x x
Cellectar Biosciences, Inc. CLRB ██% $21M x 6.2x
Clearside Biomedical, Inc. CLSDQ ██% $1M x x
Climb Bio, Inc. CLYM ██% $750M x 5.1x
Chemomab Therapeutics Ltd. CMMB ██% $11M x 0.9x
Clearmind Medicine Inc. CMND ██% $2M x x
Compass Pathways Plc CMPS ██% $1.64B x 5.0x
Cnbx Pharmaceuticals Inc. CNBX ██% N/A x x
Cns Pharmaceuticals, Inc. CNSP ██% $8M x 111.4x
Centessa Pharmaceuticals Plc CNTA ██% $6.27B x 12.9x
Connect Biopharma Holdings Ltd CNTB ██% $139M x 3.3x
Canton Strategic Holdings, Inc. CNTN ██% $167M x 0.4x
Context Therapeutics Inc. CNTX ██% $58M x 1.1x
Cocrystal Pharma, Inc. COCP ██% $13M x 3.1x
Cogent Biosciences, Inc. COGT ██% $6.77B x 11.1x
Collegium Pharmaceutical, Inc COLL ██% $1.16B 15.5x 3.7x
Corcept Therapeutics Inc CORT ██% $9.99B 211.0x 15.7x
Coya Therapeutics, Inc. COYA ██% $107M x 2.2x
China Pharma Holdings, Inc. CPHI ██% $328M x 8.9x
Cumberland Pharmaceuticals Inc CPIX ██% $118M x 5.4x
Cannapharmarx, Inc. CPMD ██% $1M x x
Catalyst Pharmaceuticals, Inc. CPRX ██% $3.85B 17.4x 3.8x
Corbus Pharmaceuticals Holdings, Inc. CRBP ██% $159M x 1.3x
Cormedix Inc. CRMD ██% $642M 3.6x 1.5x
Crinetics Pharmaceuticals, Inc. CRNX ██% $8.84B x 6.9x
Cervomed Inc. CRVO ██% $27M x 2.5x
Corvus Pharmaceuticals, Inc. CRVS ██% $1.22B x 5.1x
Cytomx Therapeutics, Inc. CTMX ██% $745M x 2.3x
Contineum Therapeutics, Inc. CTNM ██% $519M x 2.1x
Citius Oncology, Inc. CTOR ██% $53M x 1.5x
Ctt Pharmaceutical Holdings, Inc. CTTH ██% $4M x 5.1x
Citius Pharmaceuticals, Inc. CTXR ██% $15M x 0.2x
Cue Biopharma, Inc. CUE ██% $141M x 6.5x
Curanex Pharmaceuticals Inc CURX ██% $6M x 0.7x
Cadrenal Therapeutics, Inc. CVKD ██% $7M x 3.7x
Cv Sciences, Inc. CVSI ██% $4M x 2.6x
Cyclerion Therapeutics, Inc. CYCN ██% $16M x 2.3x
Cytodyn Inc. CYDY ██% $276M x x
Cypherpunk Technologies Inc. CYPH ██% $79M x 0.9x
Cryoport, Inc. CYRX ██% $815M 10.2x 1.7x
Cytokinetics Inc CYTK ██% $11.01B x x
Dare Bioscience, Inc. DARE ██% $18M x 24.8x
Decoy Therapeutics Inc. DCOY ██% $3M x 0.7x
Journey Medical Corp DERM ██% $200M x 6.5x
Diamedica Therapeutics Inc. DMAC ██% $381M x 8.1x
Damora Therapeutics, Inc. DMRA ██% $2.03B x 4.0x
Dianthus Therapeutics, Inc. /De/ DNTH ██% $5.77B x 4.8x
Dermata Therapeutics, Inc. DRMA ██% $5M x 0.8x
Bright Minds Biosciences Inc. DRUG ██% $758M x x
Design Therapeutics, Inc. DSGN ██% $753M x 3.5x
Dogwood Therapeutics, Inc. DWTX ██% $47M x 0.6x
Dyne Therapeutics, Inc. DYN ██% $3.94B x 4.6x
Emergent Biosolutions Inc. EBS ██% $396M x 0.8x
Edesa Biotech, Inc. EDSA ██% $54M x 5.3x
Pmgc Holdings Inc. ELAB ██% $5M x 0.4x
Elanco Animal Health Inc ELAN ██% $12.72B x 2.0x
Eledon Pharmaceuticals, Inc. ELDN ██% $300M x 6.7x
Elite Pharmaceuticals Inc /Nv/ ELTP ██% $408M 9.1x 4.1x
Elicio Therapeutics, Inc. ELTX ██% $81M x x
Enliven Therapeutics, Inc. ELVN ██% $3.88B x 8.6x
Emmaus Life Sciences, Inc. EMMA ██% $820K x x
Enlivex Ltd. ENLV ██% $80M 0.0x 0.0x
Ensysce Biosciences, Inc. ENSC ██% $4M x x
Enanta Pharmaceuticals Inc ENTA ██% $390M x 3.4x
Enveric Biosciences, Inc. ENVB ██% $5M x 1.1x
Evolus, Inc. EOLS ██% $382M x x
Eupraxia Pharmaceuticals Inc. EPRX ██% $417M x 5.1x
Equillium, Inc. EQ ██% $166M x 2.8x
Erasca, Inc. ERAS ██% $6.73B x 17.1x
Ernexa Therapeutics Inc. ERNA ██% $5M x 0.8x
Esperion Therapeutics, Inc. ESPR ██% $799M x x
Eton Pharmaceuticals, Inc. ETON ██% $1.18B x 38.6x
Earth Science Tech, Inc. ETST ██% $41M 8.4x 5.8x
Evofem Biosciences, Inc. EVFM ██% $1M x x
Evommune, Inc. EVMN ██% $440M x 1.5x
Edgewise Therapeutics, Inc. EWTX ██% $4.25B x 8.6x
Fortress Biotech, Inc. FBIO ██% $117M 0.9x 0.7x
Fibrobiologics, Inc. FBLG ██% $4M x 1.6x
Forte Biosciences, Inc. FBRX ██% $1.04B x 24.7x
Foghorn Therapeutics Inc. FHTX ██% $303M x x
Filana Therapeutics, Inc. FLNA ██% $49M x 0.7x
Faeth Therapeutics, Inc. FTH ██% $731M x x
Fulcrum Therapeutics, Inc. FULC ██% $245M x 0.7x
Galectin Therapeutics Inc GALT ██% $253M x x
Gain Therapeutics, Inc. GANX ██% $78M x 5.6x
Greater Cannabis Company, Inc. GCAN ██% $260K x x
Cytomed Therapeutics Ltd GDTC ██% $11M x x
Geron Corp GERN ██% $940M x 4.1x
Gh Research Plc GHRS ██% $1.76B x x
Galmed Pharmaceuticals Ltd. GLMD ██% $3M x 0.2x
Greenwich Lifesciences, Inc. GLSI ██% $215M x 40.8x
Genelux Corp GNLX ██% $130M x 5.7x
Genprex, Inc. GNPX ██% $4M x 0.2x
Gossamer Bio, Inc. GOSS ██% $76M x x
Geovax Labs, Inc. GOVX ██% $5M x 10.5x
Structure Therapeutics Inc. GPCR ██% $3.51B x 2.4x
Grace Therapeutics, Inc. GRCE ██% $40M x 0.6x
Gri Bio, Inc. GRI ██% $3M x 0.3x
Galera Therapeutics, Inc. GRTX ██% $3.38B 22.7x 4646.0x
Gsk Plc GSK ██% $101.70B x x
Gt Biopharma, Inc. GTBP ██% $13M x 1.7x
Gyre Therapeutics, Inc. GYRE ██% $676M x 6.7x
Hutchmed (China) Ltd HCM ██% $1.92B 2.1x 1.6x
Hcw Biologics Inc. HCWB ██% $5M x 0.9x
Cybin Inc. HELP ██% $502M x x
Hepion Pharmaceuticals, Inc. HEPA ██% $2M x 0.8x
Vyome Holdings, Inc HIND ██% $15M x 2.3x
Hookipa Pharma Inc. HOOK ██% $14M x 0.4x
Werewolf Therapeutics, Inc. HOWL ██% $18M x 1.5x
Harmony Biosciences Holdings, Inc. HRMY ██% $2.13B 14.6x 2.3x
Heron Therapeutics, Inc. /De/ HRTX ██% $91M x 10.0x
Hst Global, Inc. HSTC ██% $99M x 79.9x
Tuhura Biosciences, Inc./Nv HURA ██% $141M x 6.1x
Mindwalk Holdings Corp. HYFT ██% $68M x x
Hyperion Defi, Inc. HYPD ██% $42M x 0.7x
Ibio, Inc. IBIO ██% $70M x 0.9x
Impact Biomedical Inc. IBO ██% $48M x 4.2x
Ideaya Biosciences, Inc. IDYA ██% $3.16B x 3.4x
Inflarx N.V. IFRX ██% $267M x x
Igc Pharma, Inc. IGC ██% $27M x 4.4x
Immutep Ltd IMMP ██% $59M x x
Immix Biopharma, Inc. IMMX ██% $681M x 8.1x
Immunome Inc. IMNM ██% $2.58B x 4.4x
Imunon, Inc. IMNN ██% $7M x 2.0x
Immuron Ltd IMRN ██% $10M x x
Immuneering Corp IMRX ██% $288M x 1.4x
Immunic, Inc. IMUX ██% $206M x 1.4x
Integrated Biopharma Inc INBP ██% $5M x 0.3x
Indaptus Therapeutics, Inc. INDP ██% $336M x 269.1x
Indivior Pharmaceuticals, Inc. INDV ██% $5.02B 19.9x x
Inmed Pharmaceuticals Inc. INM ██% $8M x 1.2x
Inovio Pharmaceuticals, Inc. INO ██% $90M x 14.9x
Insmed Inc INSM ██% $23.52B x 33.4x
Inhibitor Therapeutics, Inc. INTI ██% $13M x x
Innoviva, Inc. INVA ██% $1.59B 3.2x 1.2x
Io Biotech, Inc. IOBTQ ██% $210K x 0.2x
Ionis Pharmaceuticals Inc IONS ██% $8.86B x 18.0x
Opus Genetics, Inc. IRD ██% $253M x x
Disc Medicine, Inc. IRON ██% $2.89B x 4.2x
Ironwood Pharmaceuticals Inc IRWD ██% $644M 6.3x x
International Stem Cell Corp ISCO ██% $1M x x
Inventiva S.A. IVA ██% $1.06B x x
Incannex Healthcare Inc. IXHL ██% $38M x 0.5x
Jaguar Health, Inc. JAGX ██% $6M x x
Janux Therapeutics, Inc. JANX ██% $990M x 1.1x
Jazz Pharmaceuticals Plc JAZZ ██% $15.74B 533.6x 3.5x
Jade Biosciences, Inc. JBIO ██% $1.25B x 4.2x
Johnson & Johnson JNJ ██% $603.64B 28.7x 7.4x
Jupiter Neurosciences, Inc. JUNS ██% $8M x x
Kala Bio, Inc. KALA ██% $14M x 1.3x
Kalvista Pharmaceuticals, Inc. KALV ██% $1.38B x x
Kairos Pharma, Ltd. KAPA ██% $8M x 1.4x
Kaya Holdings, Inc. KAYS ██% $140K x x
Kamada Ltd KMDA ██% $420M x x
Kiniksa Pharmaceuticals International, Plc KNSA ██% $4.86B 66.6x 8.0x
Kiora Pharmaceuticals Inc KPRX ██% $10M x 0.7x
Karyopharm Therapeutics Inc. KPTI ██% $177M x x
Keros Therapeutics, Inc. KROS ██% $209M x 0.7x
Korro Bio, Inc. KRRO ██% $172M x 1.4x
Pasithea Therapeutics Corp. KTTA ██% $15M x 0.3x
Kura Oncology, Inc. KURA ██% $967M x 9.0x
Kyntra Bio, Inc. KYNB ██% $30M 0.2x x
Lb Pharmaceuticals Inc LBRX ██% $926M x 2.5x
Legend Biotech Corp LEGN ██% $4.55B x x
Lexaria Bioscience Corp. LEXX ██% $14M x 2.9x
Lifecore Biomedical, Inc. \De\ LFCR ██% $174M x x
Lifevantage Corp LFVN ██% $81M 10.2x 2.4x
Ligand Pharmaceuticals Inc LGND ██% $6.12B 39.8x 6.1x
Longeveron Inc. LGVN ██% $19M x 1.2x
Lianbio LIANY ██% $12M x 0.1x
Lftd Partners Inc. LIFD ██% $3M x 0.3x
Lipella Pharmaceuticals Inc. LIPO ██% $150K x 0.1x
Lite Strategy, Inc. LITS ██% $35M x 0.6x
Lixte Biotechnology Holdings, Inc. LIXT ██% $120M x 15.2x
Lakefront Biotherapeutics Nv LKFT ██% $1.93B x x
Eli Lilly & Co LLY ██% $1.05T 41.6x 33.7x
Lunai Bioworks Inc. LNAI ██% $13M x x
Lipocine Inc. LPCN ██% $16M x 0.7x
Liquidia Corp LQDA ██% $7.14B 320.3x 65.8x
Larimar Therapeutics, Inc. LRMR ██% $408M x 2.6x
Lisata Therapeutics, Inc. LSTA ██% $20M x 1.9x
Lantern Pharma Inc. LTRN ██% $38M x 10.9x
Lexicon Pharmaceuticals, Inc. LXRX ██% $1.01B x 5.0x
Lyell Immunopharma, Inc. LYEL ██% $306M x 1.1x
Maia Biotechnology, Inc. MAIA ██% $81M x 2.9x
Veradermics, Inc MANE ██% $4.57B x 11.7x
Mustang Bio, Inc. MBIO ██% $5M x 0.5x
Moleculin Biotech, Inc. MBRX ██% $15M x 1.0x
Mbx Biosciences, Inc. MBX ██% $2.87B x 6.6x
Seres Therapeutics, Inc. MCRB ██% $50M x 1.9x
Medicus Pharma Ltd. MDCX ██% $22M x 16.6x
Madrigal Pharmaceuticals, Inc. MDGL ██% $12.60B x 23.2x
Macrogenics Inc MGNX ██% $289M x 13.6x
Mira Pharmaceuticals, Inc. MIRA ██% $39M x 4.1x
Mirum Pharmaceuticals, Inc. MIRM ██% $7.13B x 29.4x
Milestone Pharmaceuticals Inc. MIST ██% $145M x 4.0x
Moonlake Immunotherapeutics MLTX ██% $1.68B x 6.6x
Mineralys Therapeutics, Inc. MLYS ██% $2.27B x 3.6x
Mannkind Corp MNKD ██% $1.25B x x
Medicinova Inc MNOV ██% $65M x 1.7x
Monopar Therapeutics MNPR ██% $761M x 5.6x
Maplight Therapeutics, Inc. MPLT ██% $1.69B x 4.2x
Mereo Biopharma Group Plc MREO ██% $49M x 1.4x
Merck & Co., Inc. MRK ██% $312.11B 34.9x 6.8x
Marker Therapeutics, Inc. MRKR ██% $21M x 1.5x
Maravai Lifesciences Holdings, Inc. MRVI ██% $2.62B x 12.4x
Satellos Bioscience Inc. MSLE ██% $178M x x
Matinas Biopharma Holdings, Inc. MTNB ██% $2M x 0.6x
Metavia Inc. MTVA ██% $8M x 0.9x
Newamsterdam Pharma Co N.V. NAMS ██% $3.77B x 5.7x
Natures Sunshine Products Inc NATR ██% $366M 18.4x 2.2x
Novabridge Biosciences NBP ██% $212M x 0.8x
Nanobiotix S.A. NBTX ██% $1.91B x x
Newcelx Ltd. NCEL ██% $21M x 37.8x
Nucana Plc NCNA ██% $5M x x
Minerva Neurosciences, Inc. NERV ██% $196M x x
Neuphoria Therapeutics Inc. NEUP ██% $18M x 0.6x
Neurogene Inc. NGNE ██% $732M x 3.1x
Nika Pharmaceuticals, Inc NIKA ██% $806M x x
Nektar Therapeutics NKTR ██% $2.32B x 4.0x
Nkarta, Inc. NKTX ██% $192M x 0.7x
Nomad Power Solutions, Inc. NMAD ██% $99M x 12.5x
Nanoviricides, Inc. NNVC ██% $35M x 3.8x
Nurix Therapeutics, Inc. NRIX ██% $2.43B x 6.1x
Neurosense Therapeutics Ltd. NRSN ██% $25M x x
Nrx Pharmaceuticals, Inc. NRXP ██% $191M x x
Nasus Pharma Ltd NSRX ██% $35M x 12.8x
Neonc Technologies Holdings, Inc. NTHI ██% $84M x x
Nuvation Bio Inc. NUVB ██% $2.23B x 7.0x
Nuvalent, Inc. NUVL ██% $9.75B x 8.3x
Nuvectis Pharma, Inc. NVCT ██% $602M x 42.3x
Novartis Ag NVS ██% $293.61B x x
Northwest Biotherapeutics Inc NWBO ██% $273M x x
Nextcure, Inc. NXTC ██% $21M x 0.8x
Nexentis Technologies Inc. NXTS ██% $3M x 0.2x
Ocular Therapeutix, Inc OCUL ██% $1.95B x 3.4x
Oragenics Inc OGEN ██% $2M x 0.4x
Organigram Global Inc. OGI ██% $133M x x
Organon & Co. OGN ██% $3.55B 14.4x 3.9x
Onkure Therapeutics, Inc. OKUR ██% $168M x 0.9x
Olema Pharmaceuticals, Inc. OLMA ██% $1.01B x 2.1x
Omeros Corp OMER ██% $686M 8.0x x
Beone Medicines Ltd. ONC ██% $33.06B 64.5x 7.0x
Onconetix, Inc. ONCO ██% $3M x 0.3x
Oncolytics Biotech Inc ONCY ██% $100M x x
Opko Health, Inc. OPK ██% $918M x 0.8x
Organogenesis Holdings Inc. ORGO ██% $345M 126.8x 1.4x
Oric Pharmaceuticals, Inc. ORIC ██% $1.12B x 2.7x
Oruka Therapeutics, Inc. ORKA ██% $5.69B x 11.7x
Oramed Pharmaceuticals Inc. ORMP ██% $165M 1.5x 0.7x
Os Therapies Inc OSTX ██% $69M x x
Oncotelic Therapeutics, Inc. OTLC ██% $18M x 0.1x
Ovid Therapeutics Inc. OVID ██% $450M x 2.3x
One World Products, Inc. OWPC ██% $40K x x
Phibro Animal Health Corp PAHC ██% $1.37B 14.4x 3.8x
Prestige Consumer Healthcare Inc. PBH ██% $2.38B 12.5x 1.3x
Psyence Biomedical Ltd. PBM ██% $12M x x
Puma Biotechnology, Inc. PBYI ██% $437M 17.9x 3.4x
Pacira Biosciences, Inc. PCRX ██% $1.01B 197.2x 1.6x
Processa Pharmaceuticals, Inc. PCSA ██% $6M x 2.4x
Procyon Corp PCYN ██% $2M x 1.0x
Pds Biotechnology Corp PDSB ██% $42M x 10.9x
Pepgen Inc. PEPG ██% $146M x 1.1x
Pfizer Inc PFE ██% $141.93B 19.0x 1.6x
Precigen, Inc. PGEN ██% $1.95B x 96.6x
Phathom Pharmaceuticals, Inc. PHAT ██% $894M x x
Phio Pharmaceuticals Corp. PHIO ██% $13M x 0.8x
Pharvaris N.V. PHVS ██% $2.41B x x
Protokinetix, Inc. PKTX ██% $2M x 10.0x
Pliant Therapeutics, Inc. PLRX ██% $67M x 0.4x
Polaryx Therapeutics, Inc. PLYX ██% $110M x 44.2x
Polomar Health Services, Inc. PMHS ██% $3M x x
Promis Neurosciences Inc. PMN ██% $130M x 2.1x
Pmv Pharmaceuticals, Inc. PMVP ██% $70M x 0.8x
Purple Biotech Ltd. PPBT ██% $1M x x
Propanc Biopharma, Inc. PPCB ██% $3M x 0.3x
Praxis Precision Medicines, Inc. PRAX ██% $8.86B x 6.3x
Prf Technologies Ltd. PRFX ██% $4M x 0.4x
Perrigo Co Plc PRGO ██% $1.45B x 0.6x
Prelude Therapeutics Inc PRLD ██% $333M x 5.5x
Prophase Labs, Inc. PRPH ██% $980K x 0.1x
Proqr Therapeutics N.V. PRQR ██% $265M x x
Prothena Corp Public Ltd Co PRTA ██% $464M x 1.5x
Ptc Therapeutics, Inc. PTCT ██% $6.51B x x
Protagonist Therapeutics, Inc PTGX ██% $8.88B x 13.6x
Protagenic Therapeutics, Inc.\New PTIX ██% $420K x x
Palatin Technologies Inc PTN ██% $15M x 1.5x
Petros Pharmaceuticals, Inc. PTPI ██% $170K 0.0x 0.1x
Pulmatrix, Inc. PULM ██% $6M x 1.7x
Provectus Biopharmaceuticals, Inc. PVCT ██% $25M x x
Palvella Therapeutics, Inc. PVLA ██% $2.06B x 8.9x
Pyxis Oncology, Inc. PYXS ██% $140M x 4.5x
Quoin Pharmaceuticals, Ltd. QNRX ██% $9M x 1.0x
Quantum Biopharma Ltd. QNTM ██% $19M x x
Q32 Bio Inc. QTTB ██% $458M 13.8x 9.9x
Quantum Cyber N.V. QUCY ██% $26M x 5.8x
Uniqure N.V. QURE ██% $2.53B x 16.9x
Radiopharm Theranostics Ltd RADX ██% $34M x x
Rani Therapeutics Holdings, Inc. RANI ██% $95M x 3.4x
Rapport Therapeutics, Inc. RAPP ██% $2.03B x 4.3x
Ultragenyx Pharmaceutical Inc. RARE ██% $2.81B x x
Rocket Pharmaceuticals, Inc. RCKT ██% $371M x 1.6x
Arcus Biosciences, Inc. RCUS ██% $3.70B x 7.1x
Dr Reddys Laboratories Ltd RDY ██% $10.48B x x
Regeneron Pharmaceuticals, Inc. REGN ██% $70.22B 15.9x 2.2x
Revelation Biosciences, Inc. REVB ██% $4M x 0.4x
Rafael Holdings, Inc. RFL ██% $118M x 1.6x
Regen Biopharma Inc RGBP ██% $50K x x
Rigel Pharmaceuticals Inc RIGL ██% $724M 2.0x 1.8x
Rocket One Inc. RKTO ██% $19M x 4.5x
Relmada Therapeutics, Inc. RLMD ██% $556M x 2.5x
Rallybio Corp RLYB ██% $89M x 1.8x
Retrieve Medical Holdings, Inc. RMHI ██% $25M x x
Rockwell Medical, Inc. RMTI ██% $25M x 0.7x
Cartesian Therapeutics, Inc. RNAC ██% $232M x x
Transcode Therapeutics, Inc. RNAZ ██% $8M x 6.2x
Rein Therapeutics, Inc. RNTX ██% $77M x 6.6x
Renovorx, Inc. RNXT ██% $40M x 3.5x
Roivant Sciences Ltd. ROIV ██% $25.18B x 5.6x
Royalty Pharma Plc RPRX ██% $33.64B 40.7x 4.9x
Rest Ez Inc. RTEZ ██% $1.93B x x
Reviva Pharmaceuticals Holdings, Inc. RVPH ██% $6M x 0.3x
Revium Rx. RVRC ██% $101M x 16.5x
Rhythm Pharmaceuticals, Inc. RYTM ██% $7.30B x 59.4x
Rezolute, Inc. RZLT ██% $482M x 4.1x
Sunshine Biopharma Inc. SBFM ██% $3M x 0.1x
Scienture Holdings, Inc. SCNX ██% $16M x 0.2x
Scynexis Inc SCYX ██% $329M x 8.0x
Stablecoin Development Corp SDEV ██% $32M 0.1x 0.2x
Schrodinger, Inc. SDGR ██% $1.12B x 3.6x
Septerna, Inc. SEPN ██% $1.51B x 4.0x
Serina Therapeutics, Inc. SER ██% $31M x 1.8x
Sagimet Biosciences Inc. SGMT ██% $437M x 4.3x
Shuttle Pharmaceuticals Holdings, Inc. SHPH ██% $2M x 0.6x
Siga Technologies Inc SIGA ██% $257M 12.7x 1.7x
Silo Pharma, Inc. SILO ██% $5M x 0.9x
Sionna Therapeutics, Inc. SION ██% $2.13B x 7.4x
Skinvisible, Inc. SKVI ██% $1M x x
Skye Bioscience, Inc. SKYE ██% $22M x 2.5x
Sol-Gel Technologies Ltd. SLGL ██% $291M x 12.8x
Silence Therapeutics Plc SLN ██% $512M x 10.4x
Sellas Life Sciences Group, Inc. SLS ██% $2.34B x 21.8x
Summit Therapeutics Inc. SMMT ██% $11.35B x 20.8x
Semnur Pharmaceuticals, Inc. SMNR ██% $147M x x
Syndax Pharmaceuticals Inc SNDX ██% $2.00B x 48.2x
Soligenix, Inc. SNGX ██% $5M x 1.7x
Faeth Therapeutics, Inc. SNSE ██% $31M x x
Sanofi SNY ██% $105.45B x x
Spruce Biosciences, Inc. SPRB ██% $126M x 3.6x
Scisparc Ltd. SPRC ██% $3M x x
Spero Therapeutics, Inc. SPRO ██% $77M 5.0x 1.5x
Ars Pharmaceuticals, Inc. SPRY ██% $632M x 10.3x
Sarepta Therapeutics, Inc. SRPT ██% $1.71B 26.3x 1.1x
Stoke Therapeutics, Inc. STOK ██% $1.79B x 4.5x
Shattuck Labs, Inc. STTK ██% $689M x 7.2x
Supernus Pharmaceuticals, Inc. SUPN ██% $2.76B x 2.6x
Savara Inc SVRA ██% $1.20B x 6.8x
60 Degrees Pharmaceuticals, Inc. SXTP ██% $4M x 0.9x
Synlogic, Inc. SYBX ██% $8M x 0.7x
Spyre Therapeutics, Inc. SYRE ██% $7.96B x 11.9x
Takeda Pharmaceutical Co Ltd TAK ██% $55.02B x x
Theravance Biopharma, Inc. TBPH ██% $869M 7.6x 3.0x
Alaunos Therapeutics, Inc. TCRT ██% $5M x 3.7x
Telomir Pharmaceuticals, Inc. TELO ██% $79M x 15.9x
Tenax Therapeutics, Inc. TENX ██% $398M x 3.5x
Teva Pharmaceutical Industries Ltd TEVA ██% $36.21B 23.1x 4.4x
Tg Therapeutics, Inc. TGTX ██% $8.22B 17.8x 14.1x
Talphera, Inc. TLPH ██% $64M x 3.5x
Telix Pharmaceuticals Ltd TLX ██% $3.53B x x
Tango Therapeutics, Inc. TNGX ██% $4.63B x 11.8x
Tonix Pharmaceuticals Holding Corp. TNXP ██% $183M x 0.8x
Theriva Biologics, Inc. TOVX ██% $11M x 0.7x
Tempest Therapeutics, Inc. TPST ██% $16M x 19.2x
Entrada Therapeutics, Inc. TRDA ██% $245M x 0.9x
Trevi Therapeutics, Inc. TRVI ██% $2.23B x 13.0x
Turn Therapeutics Inc. TTRX ██% $297M x 48.6x
Tvardi Therapeutics, Inc. TVRD ██% $26M x 1.8x
Travere Therapeutics, Inc. TVTX ██% $5.11B x 51.8x
Therapeuticsmd, Inc. TXMD ██% $24M 133.2x 0.9x
Tyra Biosciences, Inc. TYRA ██% $1.86B x 4.8x
Unicycive Therapeutics, Inc. UNCY ██% $138M x 3.7x
Upstream Bio, Inc. UPB ██% $372M x 1.2x
Urogen Pharma Ltd. URGN ██% $2.10B x x
United Therapeutics Corp UTHR ██% $26.42B 20.5x 4.5x
Valion Bio, Inc. VBIO ██% $1M x 0.1x
Vaccinex, Inc. VCNX ██% $3M x x
Vera Therapeutics, Inc. VERA ██% $2.65B x 5.3x
Sb Technology Holdings, Inc. VGLS ██% $240K x x
Vicapsys Life Sciences, Inc. VICP ██% $47M x x
Viking Therapeutics, Inc. VKTX ██% $4.33B x 8.6x
Vanda Pharmaceuticals Inc. VNDA ██% $330M x 1.2x
Verrica Pharmaceuticals Inc. VRCA ██% $95M x 5.9x
Viridian Therapeutics, Inc.\De VRDN ██% $1.95B x 3.1x
Vireo Growth Inc. VREOD ██% $491M x 1.7x
Vireo Growth Inc. VREOF ██% $491M x 1.7x
Vertex Pharmaceuticals Inc / Ma VRTX ██% $120.75B 27.8x 6.2x
Verastem, Inc. VSTM ██% $510M x 6.2x
Vistagen Therapeutics, Inc. VTGN ██% $9M x 0.3x
Viatris Inc VTRS ██% $19.97B x 1.4x
Vyne Therapeutics Inc. VYNE ██% $29M x 1.2x
Whitehawk Therapeutics, Inc. WHWK ██% $188M x 1.6x
Wave Life Sciences Ltd. WVE ██% $1.12B x 2.2x
Xenetic Biosciences, Inc. XBIO ██% $7M x 1.0x
Xbiotech Inc. XBIT ██% $67M x 0.5x
Exicure, Inc. XCUR ██% $12M x 5.5x
Xenon Pharmaceuticals Inc. XENE ██% $6.41B x 4.8x
Xeris Biopharma Holdings, Inc. XERS ██% $1.48B 123.2x 113.7x
Xilio Therapeutics, Inc. XLO ██% $57M x 0.8x
Xencor Inc XNCR ██% $1.46B x 2.8x
Xoma Royalty Corp XOMA ██% $710M 21.0x 7.7x
Xtl Biopharmaceuticals Ltd XTLB ██% $7M x x
Zenas Biopharma, Inc. ZBIO ██% $2.07B x 6.2x
Zai Lab Ltd ZLAB ██% $2.30B x 3.5x
Zentalis Pharmaceuticals, Inc. ZNTL ██% $324M x 1.8x
Zoetis Inc. ZTS ██% $31.50B 11.9x 9.7x
Zevra Therapeutics, Inc. ZVRA ██% $730M 5.9x 3.6x
Zyversa Therapeutics, Inc. ZVSA ██% $930K x x
Reveal all forecasts See exact % predictions for all competitors
Sign up free

Frequently Asked Questions - Nrx Pharmaceuticals, Inc. Stock Forecast

How accurate are Nrx Pharmaceuticals, Inc. stock predictions?

Our AI model shows a 33% Spearman correlation coefficient for NRXP predictions, based on advanced machine learning algorithms trained on over 10 years of market data. This measures the strength of the monotonic relationship between predicted and actual price movements.

What factors influence Nrx Pharmaceuticals, Inc. stock price forecasts?

Our analysis considers Nrx Pharmaceuticals, Inc.'s financial metrics, Life Sciences sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is Nrx Pharmaceuticals, Inc. a good investment in 2025?

Based on our AI analysis, Nrx Pharmaceuticals, Inc. shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are Nrx Pharmaceuticals, Inc. forecasts updated?

Nrx Pharmaceuticals, Inc. stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want a simpler view of Nrx Pharmaceuticals, Inc.?

View simplified analysis on AI Stock Finder →

My Portfolio

Investment Dashboard

Loading your portfolio...